Shares of Spruce Biosciences, Inc. (NASDAQ: SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments.
Shares of Spruce Biosciences, Inc. (NASDAQ: SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments.
Copyright © Louis Velazquez. All Rights Reserved.